Larosa Gregory
Vice President
Disease and Inflammation Drug
Bg Enterprises Inc
Belgium
Biography
Gregory LaRosa, PhD, is Vice President, and Chief Scientific Officer of Pfizer’s Rare Disease Research Unit. Dr. LaRosa oversees all aspects of the Rare Disease Research Unit operations, including setting portfolio strategies, overseeing project progression, and working closely with the Business Unit colleagues.
Research Interest
Dr. LaRosa received his PhD from Harvard University (Division of Medical Sciences) in Molecular, Cellular, and Developmental Biology. He has over 23 years of experience in rare disease and inflammation drug discovery and development.
